Preliminary studies on the immunomodulatory effect of the C3 binding glycoprotein isolated from Cuscuta europea

International Journal of Immunopharmacology

Volumn 22, Issue 1, 2000, Pages 15-24

  Stanilova, Spaska Angelova ^a   Zhelev, Zhivko Dimitrov ^a   Dobreva, Zlatka Georgieva ^a  

^a TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

C3 component of complement; Cuscuta europea; IgM; Immunostimulation

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 2 RECEPTOR; OVALBUMIN;

ANTIBODY TITER; ARTICLE; BINDING AFFINITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION; IMMUNOMODULATION; PHENOTYPE; PLAQUE FORMING CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN ISOLATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; COMPLEMENT C3; COMPLEMENT SYSTEM PROTEINS; CYCLOPHOSPHAMIDE; GLYCOPROTEINS; IMMUNOGLOBULIN M; MALE; MICE; MICE, INBRED BALB C; PLANT PROTEINS; RECEPTORS, INTERLEUKIN-2;

EID: 0033976544     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00060-0     Document Type: Article

References (30)

1. Ahearn J.M., Fearon D.T. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46:1989;183-219.
2. Beuth J., Ko H.L., Gabius H.J., Burrichter H., Oette K., Pulverer G. Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients. Clin. Investig. 70:1992;658-661.
3. Bradbury L., Kansas G.S., Levy S., Evans R.L., Tedder T.F. CD19 is a component of a signal transducing complex on the surface of B cells that includes CD21, TAPA-1 and leu-13. J. Immunol. 149:1992;2841-2850.
4. Chevalier J., Kazatchkine M.D. Distribution in clusters of complement receptor type one (CR1) on human erythrocytes. J. Immunol. 142:1989;2031-2036.
5. Cooper N.R., Moore M.D., Nemerow G.R. Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3 d complement fragment. Annu. Rev. Immunol. 6:1988;85-113.
6. Cupps T., Edgar L.C., Fauci A.S. Suppression of human B lymphocyte function by cyclophosphsmid. J. Immunol. 126:1982;2453-2457.
7. Dempsey P., Alison M., Akkaraju S., Goodnow C., Fearon D. C3 d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 271:1996;348-350.
8. Drews J. Immunopharmacology. Principles and perspectives. 1990;Springer-Verlag, Berlin Heidelberg.
9. Edens R.E., Linhart R.J., Weiler J.M. Immobilization of C3b with retention of functional activity. J. Immunol. Methods. 133:1990;67-75.
10. Fearon D.T. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocytes, polymorphonuclear leukocytes, B lymphocytes and monocytes. J. Exp. Med. 152:1980;20-30.
11. Gabius S., Joshi S.S., Kayser K., Gabius H.J. The galactoside-specific lectin from mistletoe as biological response modifier (review). Int. J. Oncol. 1:1992;705-708.
12. Gustavsson S., Kinoshita T., Heyman B. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J. Immunol. 154:1995;6524-6528.
13. Hajto T., Hostanska K., Gabius H.J. Modulatory potency of the galactoside-specific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer. Res. 49:1989;4803-4808.
14. Hebell T., Ahearn J.M., Fearon D.T. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science. 254:1991;102-105.
15. Heyman B., Wiersma E.J., Kinoshita T. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:1990;665-668.
16. Hudson L., Hay F. Practical immunology. Enumeration of antigen-specific plasma cells. 1989;Blackwell scientific publication, Oxford. 140 pp.
17. Hudson L., Hay F. Practical immunology. Estimation of CH50 tube assay. 1989;Blackwell Scientific Publication, Oxford. 266 pp.
18. Jelinek D.F., Splawski J.B., Lipsky P.E. The role of interleukin 2 and interferon-γ in human B cell activation, growth and differentiation. Eur. J. Immunol. 16:1986;925-932.
19. Jurin M., Zarcovic N., Hrzenjak M., Ilic Z. Antitumorous and immunomodulatory effects of the Viscum album L. Preparation Isorel. Oncology. 50:1993;393-398.
20. Kinoshita T., Takeda J., Hong K., Kozono H., Sakai H., Inoue K. Monoclonal antibodies to mouse complement receptor type 1 (CR1): their use in a distribution study showing that mouse erythrocytes and platelets are CR1 negative. J. Immunol. 140:1988;3066-3072.
21. Matsumoto A.K., Kopicky-Burd J., Carter R.H., Tuveson D.A., Tedder T.F., Fearon D.T. Intersection of the complement and immune system: a signal transduction complex of the B lymphocyte containing complement receptor type 2 and CD19. J. Exp. Med. 173:1991;55-64.
22. Morrison D.C., Ryan J.L. The effect of bacterial endotoxin on host mediation system. Adv. Immunol. 28:1979;293-450.
23. O'Keefe M., Caporale L., Vogel C. A novel cleavage product of human complement component C3 with structural and functional properties of Cobra Venom Factor. The J. Biol. Chem. 263:1988;12,690-12,697.
24. Puri A., Saxena R., Saxena R.P., Saxena K.C. Immunostimulant agents from Andrographis paniculata. J. Nat. Prod. 56:1993;995-999.
25. Ross G.D., Medof M.E. Membranes complement receptors for C3. Adv. Immunol. 37:1985;217-268.
26. Thornton B., Vetvicka V., Ross G.D. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152:1994;1727-1737.
27. Thyphronitis G., Kinoshita T., Inoue K., Schweinle J.E., Tsokos G.C., Metcalf E.S., Finkelman F.D., Balow J.E. Modulation of mouse complement receptor 1 and 2 suppresses antibody responses in vivo. J. Immunol. 147:1991;224-230.
28. Wiersma E.J., Kinoshita T., Heyman B. Inhibition of immunological memory and T-independent humoral responses by monoclonal antibodies specific for murine complement receptors. Eur. J. Immunol. 21:1991;2501-2509.
29. Zhelev Z.H., Stanilova S., Carpenter B. Isolation, partial characterization and complement inhibiting activity of a new glycoprotein from Cuscuta europea. Biochem. Biophys. Res. Commun. 202:1994;186-194.
30. Zheleva A., Raikov Z., Ilarionova M., Todorov D. Spin labeled amino acid nitrosourea derivatives-synthesis and antitumour activity. Die Pharmazie. 50:1995;25-26.